Literature DB >> 21384189

Liver transplantation in the high MELD era: a fair chance for everyone?

Marcus Bahra1, Peter Neuhaus.   

Abstract

INTRODUCTION: In 2006, the model for end-stage liver disease (MELD) was introduced in Germany. Recent data clearly show a decrease of mortality on the waiting list but also a decrease of post-liver transplant survival. Several factors are discussed to be responsible for that; although, a MELD >30 is known to be major risk factor for outcome, MELD scores have increased to over 30 since introduction of the MELD system. On the other hand, the quality of donor organs is deteriorating from year to year at the same time.
RESULTS: To date, we have to face the dilemma of organ allocation to significantly sicker patients resulting in a noticeably worsening of post-orthotopic liver transplant (OLT) results. The question is how to keep an acceptable standard of post-OLT results.
CONCLUSION: Should allocation guidelines be modified? A further significant question is: How fair is the current allocation system for patients on the waiting list? Does the MELD score privileges or discriminates potential organ recipients?

Entities:  

Mesh:

Year:  2011        PMID: 21384189     DOI: 10.1007/s00423-011-0766-y

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  12 in total

1.  MELD and PELD: application of survival models to liver allocation.

Authors:  R H Wiesner; S V McDiarmid; P S Kamath; E B Edwards; M Malinchoc; W K Kremers; R A Krom; W R Kim
Journal:  Liver Transpl       Date:  2001-07       Impact factor: 5.799

2.  Increased donor risk: who should bear the burden?

Authors:  Sandy Feng
Journal:  Liver Transpl       Date:  2009-06       Impact factor: 5.799

Review 3.  Liver transplantation: the current situation.

Authors:  Rene Adam; Emir Hoti
Journal:  Semin Liver Dis       Date:  2009-02-23       Impact factor: 6.115

4.  The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.

Authors:  Tobias J Weismüller; Ahmed Negm; Thomas Becker; Hannelore Barg-Hock; Jürgen Klempnauer; Michael P Manns; Christian P Strassburg
Journal:  Transpl Int       Date:  2009-07-10       Impact factor: 3.782

5.  [Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres].

Authors:  H J Schlitt; M Loss; M N Scherer; T Becker; K-W Jauch; B Nashan; H Schmidt; U Settmacher; X Rogiers; P Neuhaus; C Strassburg
Journal:  Z Gastroenterol       Date:  2011-01-10       Impact factor: 2.000

Review 6.  The model for end-stage liver disease (MELD).

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

7.  Hyponatremia and mortality among patients on the liver-transplant waiting list.

Authors:  W Ray Kim; Scott W Biggins; Walter K Kremers; Russell H Wiesner; Patrick S Kamath; Joanne T Benson; Erick Edwards; Terry M Therneau
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

8.  Model for end-stage liver disease (MELD) and allocation of donor livers.

Authors:  Russell Wiesner; Erick Edwards; Richard Freeman; Ann Harper; Ray Kim; Patrick Kamath; Walter Kremers; John Lake; Todd Howard; Robert M Merion; Robert A Wolfe; Ruud Krom
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

9.  Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites.

Authors:  Hwan Y Yoo; David Edwin; Paul J Thuluvath
Journal:  Am J Gastroenterol       Date:  2003-06       Impact factor: 10.864

10.  Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.

Authors:  Michael L Volk; Anna S F Lok; Shawn J Pelletier; Peter A Ubel; Rodney A Hayward
Journal:  Gastroenterology       Date:  2008-11       Impact factor: 22.682

View more
  9 in total

1.  Value of the SOFA score as a predictive model for short-term survival in high-risk liver transplant recipients with a pre-transplant labMELD score ≥ 30.

Authors:  Harald Schrem; Melanie Reichert; Benedikt Reichert; Thomas Becker; Frank Lehner; Moritz Kleine; Hüseyin Bektas; Kai Johanning; Christian P Strassburg; Jürgen Klempnauer
Journal:  Langenbecks Arch Surg       Date:  2011-12-06       Impact factor: 3.445

Review 2.  Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance.

Authors:  Christoph G Dietrich; Oliver Götze; Andreas Geier
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Statistical approach to quality assessment in liver transplantation.

Authors:  Harald Schrem; Sophia Volz; Hans-Friedrich Koch; Jill Gwiasda; Priscila Kürsch; Alon Goldis; Daniel Pöhnert; Markus Winny; Jürgen Klempnauer; Alexander Kaltenborn
Journal:  Langenbecks Arch Surg       Date:  2017-09-09       Impact factor: 3.445

4.  Liver transplantation in adults: Choosing the appropriate timing.

Authors:  Maria Siciliano; Lucia Parlati; Federica Maldarelli; Massimo Rossi; Stefano Ginanni Corradini
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-08-06

5.  Association of serum zinc levels with liver function and survival in patients awaiting liver transplantation.

Authors:  Kilian Friedrich; Carina Baumann; Maik Brune; Andreas Wannhoff; Christian Rupp; Sabine G Scholl; Christoph Antoni; Matthias Dollinger; Christoph Neumann-Haefelin; Karl Heinz Weiss; Wolfgang Stremmel; Peter Schemmer; Daniel Nils Gotthardt
Journal:  Langenbecks Arch Surg       Date:  2015-08-26       Impact factor: 3.445

6.  Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial.

Authors:  Bjorn Nashan; Peter Schemmer; Felix Braun; Markus Dworak; Peter Wimmer; Hans Schlitt
Journal:  Trials       Date:  2015-03-26       Impact factor: 2.279

7.  Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates.

Authors:  Philip G Ferstl; Natalie Filmann; Eva-Maria Heilgenthal; Andreas A Schnitzbauer; Wolf O Bechstein; Volkhard A J Kempf; David Villinger; Tilman G Schultze; Michael Hogardt; Christoph Stephan; Haitham Mutlak; Nina Weiler; Marcus M Mücke; Jonel Trebicka; Stefan Zeuzem; Oliver Waidmann; Martin-Walter Welker
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

8.  Patients Benefit from Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria without Harming the Health Care System.

Authors:  Jan-Paul Gundlach; Michael Linecker; Henrike Dobbermann; Felix Wadle; Thomas Becker; Felix Braun
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

9.  Evaluating twenty-years of follow-up after orthotopic liver transplantation, best practice for donor-recipient matching: What can we learn from the past era?

Authors:  Niklas Buescher; Daniel Seehofer; Michael Helbig; Andreas Andreou; Marcus Bahra; Andreas Pascher; Johann Pratschke; Wenzel Schoening
Journal:  World J Transplant       Date:  2016-09-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.